VAGLIO, AUGUSTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.203
EU - Europa 5.476
AS - Asia 1.672
OC - Oceania 85
AF - Africa 51
SA - Sud America 11
Totale 14.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.179
RU - Federazione Russa 2.651
IE - Irlanda 935
IT - Italia 761
HK - Hong Kong 522
SG - Singapore 501
SE - Svezia 477
CN - Cina 289
PL - Polonia 247
IN - India 202
AU - Australia 85
DE - Germania 82
GB - Regno Unito 67
FI - Finlandia 62
JO - Giordania 53
CH - Svizzera 49
CI - Costa d'Avorio 48
ID - Indonesia 45
FR - Francia 24
BE - Belgio 23
NL - Olanda 22
ES - Italia 20
UA - Ucraina 20
CA - Canada 19
VN - Vietnam 15
AT - Austria 14
JP - Giappone 11
BR - Brasile 8
IL - Israele 8
TR - Turchia 8
KR - Corea 7
MK - Macedonia 5
MX - Messico 5
GR - Grecia 4
LU - Lussemburgo 4
TH - Thailandia 4
PE - Perù 3
PS - Palestinian Territory 3
DK - Danimarca 2
KZ - Kazakistan 2
NG - Nigeria 2
PT - Portogallo 2
BG - Bulgaria 1
LT - Lituania 1
ME - Montenegro 1
NO - Norvegia 1
RO - Romania 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
Totale 14.498
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.402
Dublin 935
Fairfield 722
Singapore 422
Ashburn 372
Hong Kong 316
Woodbridge 296
Chandler 291
Lawrence 281
Altamura 274
Seattle 260
Houston 259
Warsaw 247
Cambridge 226
Moscow 204
Wilmington 183
Mumbai 171
Princeton 168
Boston 160
Ann Arbor 134
Florence 129
Melbourne 85
Beijing 71
San Diego 67
Buffalo 66
Shanghai 55
Bern 49
Abidjan 48
Helsinki 45
Milan 45
Jakarta 44
New York 39
Kent 35
Falls Church 34
Hillsboro 31
Medford 31
Boardman 29
Los Angeles 27
West Jordan 26
Rome 23
London 22
Norwalk 22
Guangzhou 21
Brussels 20
Pune 17
Yubileyny 17
Washington 16
Andover 15
Bologna 15
Bremen 15
Lappeenranta 14
Toronto 14
Redmond 13
Vienna 13
Dong Ket 12
Munich 11
Parma 10
Redwood City 10
Genoa 9
Laurel 9
Arezzo 8
Chicago 8
Kilburn 8
Paris 8
Chennai 7
Naples 7
Seoul 7
Barcelona 6
Hangzhou 6
Pamplona 6
Rolla 6
Romola 6
Tokyo 6
Castelliri 5
Mexico City 5
Nuremberg 5
Ottawa 5
Pisa 5
Prescot 5
Ankara 4
Atlanta 4
Bangkok 4
Bergamo 4
Capaccio 4
Changsha 4
Clifton 4
Dudelange 4
Frankfurt am Main 4
Padova 4
Reggio Nell'emilia 4
Shtip 4
Siena 4
Tel Aviv 4
Trumbull 4
Bari 3
Besançon 3
Coventry 3
Falkenstein 3
Fremont 3
Hounslow 3
Totale 9.794
Salva come PNG Salva come JPEG
Nome #
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 173
ANCA-associated vasculitis in childhood: Recent advances 171
Thrombosis in vasculitis: from pathogenesis to treatment 161
A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility 146
Reverse phenotyping after whole-Exome sequencing in steroid-resistant nephrotic syndrome 144
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 138
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 128
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 125
Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19) 123
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome 122
The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy 118
IgG4-related disease: advances in pathophysiology and treatment 115
Association of serum C3 concentration and histologic signs of thrombotic microangiopathy with outcomes among patients with ANCA-associated renal vasculitis 115
Significance of PR3-ANCA Positivity in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) 115
Brief Report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein purpura) 114
OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 113
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 110
P1813CLINICAL CHARACTERIZATION OF CONGENITAL SOLITARY FUNCTIONING KIDNEY IN CHILDREN 109
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 109
EBV-Associated Leukoencephalopathy with Late Onset of Central Nervous System Lymphoma in a Kidney Transplant Recipient 105
Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients 104
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 104
Erdheim–Chester disease: a rapidly evolving disease model 102
Fcγ-receptor 3B (FCGR3B) copy number variations in patients with eosinophilic granulomatosis with polyangiitis 102
Rituximab for chronic periaortitis without evidence of IgG4-related disease: A long-term follow-up study of 20 patients 101
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 98
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 98
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 97
A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon 96
Anca testing: where are we now? 96
Fibrocytes in Chronic Periaortitis: A Novel Mechanism Linking Inflammation and Fibrosis 96
A TNFSF13B Functional Variant Is Not Involved in Systemic Sclerosis and Giant Cell Arteritis Susceptibility 95
null 94
Asbestos and Smoking as Risk Factors for Idiopathic Retroperitoneal Fibrosis 93
Eosinophilic granulomatosis with polyangiitis: Understanding the disease and its management 93
A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases 91
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes 90
Correction: Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 89
Association of a polymorphism of the Fcγ-receptor 2A (FCGR2A) gene with chronic periaortitis 88
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update 87
Evidence of subclinical atherosclerosis in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 87
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study 87
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis 86
Long-term follow-up of mTOR inhibition for erdheim-chester disease 86
298. RITUXIMAB FOR DIFFICULT-TO-TREAT CHRONIC PARIAORTITIS: A CASE-SERIES OF 20 PATIENTS 85
Adult-onset IgA vasculitis (Henoch-Schönlein): Update on therapy 85
135. ATHERO-THROMBOTIC AND VENOUS EVENTS (AVTE) IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A MULTICENTRE STUDY OF 573 ITALIAN PATIENTS 84
Microarray evaluation of allergen-specific IgE in eosinophilic granulomatosis with polyangiitis 84
Rituximab therapy for chronic periaortitis 83
Slowly progressive ANCA-associated renal vasculitis. Clinico-pathological characterisation and outcome 83
Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis 82
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult 81
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group 80
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 77
Idiopathic Mediastinal Fibrosis: a Systemic Immune-Mediated Disorder. A Case Series and a Review of the Literature 77
At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement 76
Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA) 76
Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis? 76
Long-term disease control in granulomatosis with polyangiitis: Is low-dose rituximab the cure? 76
Neutrophil Extracellular Traps in the Autoimmunity Context 76
Type I interferon-related kidney disorders 75
Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-alpha (IFN-alpha) in Operable Renal Cell Carcinoma (RCC): A Phase III, Randomized, Multicentre Trial of the Italian Oncology Group for Clinical Research (GOIRC) 75
SARS-CoV-2 infection among patients with systemic autoimmune diseases 73
Collapsing Glomerulopathy as a Complication of Type I Interferon–Mediated Glomerulopathy in a Patient With RNASEH2B-Related Aicardi-Goutières Syndrome 73
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis 72
[18F]-Fluorodeoxyglucose Positron Emission Tomography and Response to Therapy in Idiopathic Retroperitoneal Fibrosis 72
Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management 71
IgG4-related disease: Not just a matter of IgG4 71
Aortitis and periaortitis: The puzzling spectrum of inflammatory aortic diseases 70
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis 69
Proteinuria selectivity index predicts response to rituximab in adults with minimal change disease and focal segmental glomerulosclerosis 69
Low-dose tocilizumab for relapsing giant cell arteritis in the elderly, fragile patient: Beyond the GiACTA trial 68
Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts 68
A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA 68
Occupational Exposures and Smoking in Eosinophilic Granulomatosis With Polyangiitis: A Case–Control Study 68
Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis 67
Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis 67
The Sound of Interconnectivity; The European Vasculitis Society 2022 Report 67
Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease 67
Idiopathic retroperitoneal fibrosis: an update for nephrologists 67
Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis 66
Kidney involvement in Rosai-Dorfman disease 66
Sirolimus plus prednisone for Erdheim-Chester disease: An open-label trial 66
Treatment of idiopathic retroperitoneal fibrosis 65
Skull Base Manifestations of Erdheim-Chester Disease: A Case Series and Systematic Review 65
Chronic periaortitis: A clinical approach 64
Candida sake as the causative agent of spondylodiscitis in a hemodialysis patient 64
Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study 64
F-18-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis 62
Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis 62
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management 61
IgG4-related disease: a contemporary review 61
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients 61
Chronic periaortitis: a large-vessel vasculitis? 60
CKD therapy to improve outcomes of immune-mediated glomerular diseases 59
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 59
Evidence for charge-based mimicry in anti dsDNA antibody generation 59
“Multi-autoantibody Signature and Clinical Outcome in Membranous Nephropathy” 59
IgG4 immune response in Churg-Strauss syndrome 59
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis 59
Totale 8.733
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.908
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020354 0 0 0 0 0 0 60 62 62 44 56 70
2020/20211.966 36 75 27 51 189 840 91 54 210 112 61 220
2021/20221.035 16 21 100 37 26 140 11 88 67 84 101 344
2022/20232.999 258 725 163 188 83 576 464 121 216 30 78 97
2023/20241.532 40 78 282 82 86 235 78 293 42 183 77 56
2024/20256.761 384 1.108 586 1.457 2.218 935 73 0 0 0 0 0
Totale 14.885